Literature DB >> 15551184

Primary peripheral T-cell lymphoma of the central nervous system.

A M Stark1, M Tiemann, L Dörner, E Melnikowa, H M Mehdorn, U Blömer.   

Abstract

UNLABELLED: A 47-year-old man was admitted to our hospital with a nine-week history of visual disturbance, headache, disorientation and facial nerve palsy. Serial cranial magnetic resonance imaging (MRI) revealed progressive bilateral occipital edema with hemorrhage and meningeal involvement. There were no hints of hereditary or acquired immunodeficiency. Laboratory examination for bacterial and viral causes was negative. Open brain biopsy revealed primary central nervous system lymphoma of the extraordinary rare so-called "peripheral" T-cell type. The further course was fatal; the patient died 10 weeks after the onset of symptoms from tumor progression before planned chemotherapy could be started.
CONCLUSION: If primary central nervous system lymphoma (PCNSL) is suspected, brain biopsy -- either open biopsy or stereotactic biopsy -- should be performed straight away to enable a rapid start of chemotherapy and/or radiotherapy. Peripheral T-cell lymphoma was highly aggressive in this case leading to the patient's death within several weeks.

Entities:  

Mesh:

Year:  2004        PMID: 15551184     DOI: 10.1055/s-2004-822786

Source DB:  PubMed          Journal:  Zentralbl Neurochir        ISSN: 0044-4251


  3 in total

1.  Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis.

Authors:  Netta Levin; Dov Soffer; Sigal Grissaru; Natasha Aizikovich; J Moshe Gomori; Tali Siegal
Journal:  J Neurooncol       Date:  2008-07-01       Impact factor: 4.130

2.  [Primary cerebellar T-cell lymphoma].

Authors:  A Zimpfer; M Wasner; F Fend; M Tolnay; S Dirnhofer
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

3.  Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes.

Authors:  Taekyu Lim; Seok Jin Kim; Kihyun Kim; Jung-Il Lee; Do Hoon Lim; Duk Joo Lee; Kyung Kee Baek; Ha Yeon Lee; Boram Han; Ji Eun Uhm; Young Hyeh Ko; Won Seog Kim
Journal:  Ann Hematol       Date:  2011-04-09       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.